Skip to content
Optionomics

CD earnings analysis

10-Q · Filed November 13, 2026 · Our reading of the company's report

The latest report

Reported revenue increased to $1.812 million and diluted EPS improved to $0.002, reversing the losses reported in the first two quarters of 2026. However, the extracted filing does not provide current gross margin,…

Read full summary

Reported revenue increased to $1.812 million and diluted EPS improved to $0.002, reversing the losses reported in the first two quarters of 2026. However, the extracted filing does not provide current gross margin, operating margin, free cash flow, balance-sheet, cash-flow, or segment data, preventing a complete operating assessment. The principal negative is that disclosure controls remained ineffective as of September 30, 2026 due to 3 material weaknesses. No quantitative guidance was provided.

Read the original on SEC.gov

Reported figures

Earnings per share
$0.002

What stood out

  • Revenue accelerated sharply

    Revenue was $1.812 million, up approximately 291% from $463,206 in 2026Q2 and approximately 257% from $507,546 in 2026Q1.

  • EPS turned positive

    Diluted EPS was $0.002, improving from a loss of $0.01 in 2026Q2 and a loss of $0.02 in 2026Q1.

  • No material legal proceedings

    The company reported no material pending legal proceedings, stating that there are 0 such proceedings currently pending.

What to watch

  • Material control weaknesses persist

    Management concluded that disclosure controls were not effective as of September 30, 2026 because of 3 identified material weaknesses: insufficient documentation, limited segregation of duties, and inadequate U.S. GAAP/SEC-reporting personnel and infrastructure.

  • Limited risk disclosure

    The company qualifies as a smaller reporting company and is not required to provide market-risk disclosures under Item 3 or a risk-factor update under Item 1A, limiting visibility into quantified market risks; both disclosures are omitted from this filing.

Management's outlook

No quantitative revenue or EPS guidance was provided in the extracted 10-Q. The filing does not include an outlook or liquidity outlook discussion.

This is our reading of a public filing, not the filing itself. Analysis can contain errors; check the source document for full context.

See every CD trade live.

The free pages stop at the last full session. Trader shows every trade as it prints.

Start tracking No card needed.